Page 1063 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

10 References

269. Akova M, Paesmans M, Calandra T, Viscoli C. A European 284. Maertens J, Buve K, Theunissen K, et al. Galactomannan
Organization for Research and Treatment of Cancer- serves as a surrogate endpoint for outcome of pulmonary inva-
International Antimicrobial Therapy Group Study of second- sive aspergillosis in neutropenic hematology patients. Cancer.
ary infections in febrile, neutropenic patients with cancer. Clin 2008;115(2):355-362.
Infect Dis. 2005;40(2):239-245. 285. Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar
270. Zaas AK, Song X, Tucker P, Perl TM. Risk factors for devel- lavage fluid galactomannan for the diagnosis of invasive pul-
opment of vancomycin-resistant enterococcal bloodstream monary aspergillosis in patients with hematologic diseases. Clin
infection in patients with cancer who are colonized with Infect Dis. December 1, 2009;49(11):1688-1693.
vancomycin-resistant enterococci. Clin Infect Dis. November 15, 286. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergil-
2002;35(10):1139-1146. losis in acute leukemia: correlation with nose cultures and anti-
271. Fleischhack G, Hartmann C, Simon A, et al. Meropenem versus biotic use. Ann Intern Med. 1979;90(1):4-9.
ceftazidime as empirical monotherapy in febrile neutropenia 287. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The
of paediatric patients with cancer. J Antimicrob Chemother. value of fungal surveillance cultures as predictors of systemic
2001;47(6):841-853. fungal infections. J Infect Dis. 1980;142(4):503-509.
272. Bow EJ, Evans G, Fuller J, et al. Canadian clinical practice guide- 288. Wingard JR. Importance of Candida species other than C.
lines for invasive candidiasis in adults. Can J Infect Dis Med albicans as pathogens in oncology patients. Clin Infect Dis.
Microbiol. 2010;21(4):e122-e150. 1995;20(1):115-125.
273. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric 289. Ostrosky-Zeichner L, Pappas PG, Shoham S, et al. Improvement of
antibiotic and antifungal therapy for cancer patients with a clinical prediction rule for clinical trials on prophylaxis for inva-
prolonged fever and granulocytopenia. Am J Med. sive candidiasis in the intensive care unit. Mycoses. July 21, 2009.
1982;72(1):101-111. 290. Ostrosky-Zeichner L, Sable C, Sobel J, et al. Multicenter retro-
274. Group EIATP. Empiric antifungal therapy in febrile granulocy- spective development and validation of a clinical prediction rule
topenic patients. EORTC International Antimicrobial Therapy for nosocomial invasive candidiasis in the intensive care setting.
Cooperative Group. Am J Med. 1989;86(6, pt 1):668-672. Eur J Clin Microbiol Infect Dis. 2007;26(4):271-276.
275. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin 291. Kappe R, Schulze-Berge A. New cause for false-positive results
B for empirical therapy in patients with persistent fever and with the Pastorex Aspergillus antigen latex agglutination test.
neutropenia. New Engl J Med. 1999;340(10):764-771. J Clin Microbiol. 1993;31(9):2489-2490.
276. Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus 292. Latge JP. The pathobiology of Aspergillus fumigatus. Trends
liposomal amphotericin B for empirical antifungal therapy in Microbiol. 2001;9(8):382-389.
patients with persistent fever and neutropenia. N Engl J Med. 293. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol
2004;351(14):1391-1402. Rev. 1999;12(2):310-350.
277. Boogaerts M, Garber G, Winston D, et al. Itraconazole com- 294. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galac-
pared to amphotericin B as empirical therapy for persistent tomannan detection in the diagnosis of invasive aspergillosis in
fever of unknown origin in neutropenic patients. Bone Marrow cancer patients. J Clin Oncol. 2002;20(7):1898-1906.
Transplant. 1999;23(suppl 1):S111. 295. Stynen D, Sarfati J, Goris A, et al. Rat monoclonal anti-
278. Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared bodies against Aspergillus galactomannan. Infect Immun.
with liposomal amphotericin B for empirical antifungal therapy 1992;60(6):2237-2245.
in patients with neutropenia and persistent fever. N Engl J Med. 296. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich
January 24, 2002;346(4):225-234. enzyme-linked immunosorbent assay to detect galactofuran
279. Kanda Y, Yamamoto R, Chizuka A, et al. Prophylactic action in patients with invasive aspergillosis. J Clin Microbiol.
of oral fluconazole against infection in neutropenic patients— 1995;33(2):497-500.
a meta-analysis of 16 randomized, controlled trials. Cancer. 297. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE.
2000;89:1611-1625. Specificity of a sandwich enzyme-linked immunosorbent assay
280. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, for detecting Aspergillus galactomannan. J Clin Microbiol.
Ioannou S. Antifungal prophylaxis for severely neutropenic che- 1997;35(1):257-260.
motherapy recipients: a meta analysis of randomized-controlled 298. Ansorg R, van den BR, Rath PM. Detection of Aspergillus
clinical trials. Cancer. 2002;94(12):3230-3246. galactomannan antigen in foods and antibiotics. Mycoses.
281. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. 1997;40(9-10):353-357.
fluconazole or itraconazole prophylaxis in patients with neutro- 299. Gangneux JP, Lavarde D, Bretagne S, Guiguen C, Gandemer V.
penia. New Engl J Med. 2007;356(4):348-359. Transient aspergillus antigenaemia: think of milk. Lancet.
282. Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and 2002;359(9313):1251.
computed tomography-based preemptive antifungal therapy in 300. Siemann M, Koch-Dorfler M, Gaude M. False-positive
neutropenic patients at high risk for invasive fungal infection: results in premature infants with the Platelia Aspergillus
a prospective feasibility study. Clin Infect Dis. November 1, sandwich enzyme-linked immunosorbent assay. Mycoses.
2005;41(9):1242-1250. 1998;41(9-10):373-377.
283. Maertens J, Van EJ, Verhaegen J, Verbeken E, Verschakelen J, 301. Husby S, Jensenius JC, Svehag SE. Passage of undegraded
Boogaerts M. Use of circulating galactomannan screening for dietary antigen into the blood of healthy adults. Quantification,
early diagnosis of invasive aspergillosis in allogeneic stem cell estimation of size distribution, and relation of uptake to levels
transplant recipients. J Infect Dis. 2002;186(9):1297-1306. of specific antibodies. Scand J Immunol. 1985;22(1):83-92.

Section05-O-ref.indd 10 1/20/2015 4:51:20 PM